<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">Similar to the cases of SARS and MERS infection, no effective therapies with proven efficacy have been developed as yet against COVID-19. Therefore, recommendations for therapeutic intervention (including supportive therapy) have been based on extrapolation of published guidelines or expert consensus 
 <xref rid="b0390" ref-type="bibr">[78]</xref>. Most pharmacological treatments were extrapolated from treatments used during the SARS or MERS outbreaks. The main findings from the clinical trials of COVID-19 in mainland China were summarized in 
 <xref rid="t0005" ref-type="table">Table 1</xref> . However, at the initial stage of the COVID-19, few clinical trial findings were available to inform clinicians regarding which medications had the greatest efficacy in treating patients with COVID-19 and whether targeted therapies existed for COVID-19.
</p>
